SYRE (STOCKS)
Spyre Therapeutics, Inc. Common Stock
$103.630000
+1.780000 (+1.75%)
Prev close: $101.850000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Pharmaceuticals Major
- CEO
- Cameron Turtle, PhD
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $9,121.68M
- Employees
- 95
- P/E (TTM)
- -47.54
- P/B (TTM)
- 9.56
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
11
Strong Buy
10
Buy
2
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Jun 2026 (Q2)
|
$-0.36 | $-0.77 | +0.4138 | +53.48% |
|
Mar 2026 (Q1)
|
$-0.74 | $-0.68 | -0.0606 | -8.92% |
|
Dec 2025 (Q4)
|
$-0.70 | $-0.79 | +0.0903 | +11.43% |
|
Sep 2025 (Q3)
|
$-0.15 | $-0.76 | +0.6113 | +80.30% |